Revolution Medicines, Inc. cotiza a 189.76 USD y tiene una capitalización bursátil de $40.7B. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in comb…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $-3.06 | $-2.29 | $-1.86 |
| Estimado | $-2.39 | $-2.06 | $-1.84 | $-1.56 |
| Sorpresa | — | -48.5% | -24.5% | -19.2% |
| Métrica | RVMD | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -69.3% | -40.4% | -28.9% |
| ROA | -48.0% | -32.0% | -16.0% |
| Current Ratio | 7.14 | 2.84 | +4.30 |
| Debt / Equity | — | 0.28 | — |